Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately Impaired Renal Function”

245 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 245 results

Early research (Phase 1)Study completedNCT01901133
What this trial is testing

Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group

Who this might be right for
Pharmacokinetics of MDV3100Healthy SubjectsKidney Diseases
Astellas Pharma Europe B.V. 33
Early research (Phase 1)Study completedNCT02048787
What this trial is testing

Pharmacokinetic Study of Buparlisib in Subjects With Renal Impairment.

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 19
Post-approval studies (Phase 4)Study completedNCT00828737
What this trial is testing

Safety of Gadovist in Renally Impaired Patients

Who this might be right for
FibrosisRenal Impairment
Bayer 927
Early research (Phase 1)Study completedNCT01512849
What this trial is testing

Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 24
Not applicableStudy completedNCT02209402
What this trial is testing

ENdothelial DysfUnction in Renal Disease and Exercise Training

Who this might be right for
Chronic Kidney Disease
Universiteit Antwerpen 40
Early research (Phase 1)Study completedNCT03687554
What this trial is testing

Effect of Venglustat in Patients With Renal Impairment

Who this might be right for
Healthy VolunteersPolycystic Kidney, Autosomal Dominant
Genzyme, a Sanofi Company 24
Not applicableStudy completedNCT00744939
What this trial is testing

Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist

Who this might be right for
FibrosisKidney FailureRenal Insufficiency
Bayer 168
Early research (Phase 1)Study completedNCT02011490
What this trial is testing

Pharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616-105)

Who this might be right for
Renal InsufficiencyRenal Impairment
Merck Sharp & Dohme LLC 33
Post-approval studies (Phase 4)Study completedNCT02864199
What this trial is testing

Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 63
Large-scale testing (Phase 3)Active Not RecruitingNCT06297603
What this trial is testing

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 320
Post-approval studies (Phase 4)Study completedNCT00786136
What this trial is testing

Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes

Who this might be right for
Diabetes MellitusChronic Kidney Disease
Shenyang Northern Hospital 2,998
Early research (Phase 1)Study completedNCT03097016
What this trial is testing

Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Insufficiency
Celgene 48
Early research (Phase 1)Not Yet RecruitingNCT07322016
What this trial is testing

HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Who this might be right for
Hyperlipidemias
Shandong Suncadia Medicine Co., Ltd. 36
Large-scale testing (Phase 3)Study completedNCT00663260
What this trial is testing

Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 631
Early research (Phase 1)Ended earlyNCT02679131
What this trial is testing

To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.

Who this might be right for
Relapsed/Refractory Solid Tumors/Hematological Malignancies
Acrotech Biopharma Inc. 18
Large-scale testing (Phase 3)Study completedNCT01204528
What this trial is testing

Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Danderyd Hospital 36
Early research (Phase 1)Study completedNCT00543075
What this trial is testing

Pharmacokinetic Study of Genasense in Subjects With Normal Renal Function, Mildly Impaired Renal Function, and Moderately Impaired Renal Function

Who this might be right for
Normal Renal FunctionMildly Impaired Renal FunctionModerately Impaired Renal Function
Genta Incorporated 23
Large-scale testing (Phase 3)Study completedNCT01020487
What this trial is testing

Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease Stage 3 and 4
AbbVie (prior sponsor, Abbott) 47
Early research (Phase 1)Study completedNCT01766154
What this trial is testing

Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function

Who this might be right for
Renal Insufficiency
Medicure 25
Large-scale testing (Phase 3)Study completedNCT02578394
What this trial is testing

Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study

Who this might be right for
GoutChronic Kidney Diseases
Mid and South Essex NHS Foundation Trust 21
Load More Results